Affiliation:
1. Cerexa, Inc., Alameda, California
2. Eurofins Medinet, Herndon, Virginia
Abstract
ABSTRACT
This study evaluated the in vitro activity of ceftaroline, a novel cephalosporin with broad-spectrum activity against gram-negative and -positive pathogens, against 4,151 recent clinical isolates collected in the United States. Ceftaroline was very potent against bacteria found in community- and hospital-acquired infections, including methicillin-resistant
Staphylococcus aureus
, multidrug-resistant
Streptococcus pneumoniae
, and common
Enterobacteriaceae
spp.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献